Vaxxinova International B.V. – Trademark Portfolio
Entity Type: 16
Vaxxinova International B.V. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include VAXXIKNOWLEDGE.
Transistorweg 5
NL-6534 AT Nijmegen
Showing of trademarks Trademarks
Trademark Classifications
Vaxxinova International B.V.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Vaxxinova International B.V. have?
Vaxxinova International B.V. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered.
What trademark classes does Vaxxinova International B.V. file in?
Vaxxinova International B.V. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 41 (Education & Entertainment), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Vaxxinova International B.V.'s most well-known trademarks?
Vaxxinova International B.V.'s registered trademark portfolio includes well-known marks such as VAXXIKNOWLEDGE. These are among 1 currently registered trademark in the portfolio.
What is Vaxxinova International B.V.'s trademark registration success rate?
Vaxxinova International B.V. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.